Abstract: Maintaining information for a traveler includes creating a virtual travel credential containing information from a physical passport of the traveler and/or physical travel document(s) of the traveler, storing at least a portion of the virtual travel credential in a mobile device carried by the traveler, monitoring a location of the mobile device, and providing a signal in response to the mobile device transitioning from a first country/territory to a second country/territory. Monitoring the location of the mobile device may include detecting a cellular network in communication with the mobile device or using GPS functionality of the mobile device or receiving information that the traveler boarded a plane headed for the second country/territory. At least a portion of the virtual travel credential may be stored in a virtual travel credential server. The virtual travel credential server may communicate with the mobile device using a cellular network.

Abstract: Maintaining information for a traveler includes creating a virtual travel credential containing information from a physical passport of the traveler and/or physical travel document(s) of the traveler, storing at least a portion of the virtual travel credential in a mobile device carried by the traveler, monitoring a location of the mobile device, and providing a signal in response to the mobile device transitioning from a first country/territory to a second country/territory. Monitoring the location of the mobile device may include detecting a cellular network in communication with the mobile device or using GPS functionality of the mobile device or receiving information that the traveler boarded a plane headed for the second country/territory. At least a portion of the virtual travel credential may be stored in a virtual travel credential server. The virtual travel credential server may communicate with the mobile device using a cellular network.

Abstract: This invention relates to a chewable lanthanum formulation comprising a pharmaceutically effective amount of a lanthanum compound; and at least one chewable pharmaceutically acceptable excipient. This invention also relates to a pharmaceutical formulation in a tablet or in a powder comprising a pharmaceutically effective amount of a lanthanum compound produced by a process which comprises the steps of: a) powder blending the lanthanum compound and at least one pharmaceutically acceptable excipient in a mixer to form a mixture; or b) powder blending the lanthanum compound and excipients, compressing the resulting combination into a slug material or roller compacting the resulting combination into a strand material, and milling the prepared material into a free flowing mixture; and c)compressing the resulting mixture into a tablet or filing up the resulting mixture in a appropriate container.